Canada’s Laipac to launch world’s first AI Rapid Antigen Test System with two UAE firms

By Shilpa Annie Joseph, Trainee Reporter
  • Follow author on
Look SPOT
Representational Image

Canada-based award-winning leader in the development of IoMT (Internet of Medical Things), Laipac Technology has partnered with two UAE healthcare companies YAS Pharmaceuticals and Pure Health, to launch the world’s first Rapid COVID-19 Antigen Test System using Artificial Intelligence (AI).

The LooK SPOT solution is a smart and innovative way to implement technologies to better protect the health of people all over the region. The European CE-IVD approved LooK SPOT AI COVID-19 Antigen Rapid Test System is a smartphone-based diagnostic device with lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein from SARS-CoV-2 in nasal swabs.

The LooK SPOT Artificial Intelligence Ecosystem transforms medical diagnostics, allowing early disease detection with consistent and accurate results.

Diego Lai
Diego Lai
Co-Founder & CEO
Laipac

“LooK SPOT’s AI Algorithm has high accuracy and can identify the color signal on tests in low positive cases when human eyes cannot, therefore eliminating the human error and manual process done with other Antigen tests available in the market. LooK SPOT reduces healthcare responders’ cognitive load by providing accurate test results in an easy-to-read format. LooK SPOT has been designed with a tactical edge to fight COVID-19.”

LooK SPOT AI COVID-19 Antigen Rapid Test utilizes the nasal sample collected from 1 inch in the nostril, and it uses AI technology to produce real-time test results with 97.4 percent sensitivity and 98.3 percent accuracy in detecting the SARS-CoV-2 virus. It can also detect the new variant of the SARS-CoV-2 virus which was first identified in the UK and South Africa.

LooK PASS App can be downloaded from Apple or Google stores, to scan the LooK COVID-19 antigen cassette before the test, and the results can be received on smartphones within 5 to 8 minutes. Negative test results generate a QR code on the application which may be used as a Pass to enter a facility, events, gatherings, or used for transport facilities. Via Pure Health, LooK SPOT will be able to offer a full API integration with multiple IT applications and travel applications for real-time reporting.

The Artificial Intelligence Rapid Antigen Test will be exhibited at the LooK SPOT Stand 03-C22 at IDEX 2021 Abu Dhabi between 21-25 February.

Stay Updated: Abu Dhabi-based Rafed, G42 Healthcare unite for swift COVID-19 vaccine logistics

YOU MAY LIKE